Price (delayed)
$7.05
Market cap
$65.56M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.1
Enterprise value
$62.73M
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data
There are no recent dividends present for KOSS.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.